A detailed history of Massachusetts Financial Services CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 348,540 shares of BIO stock, worth $130 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
348,540
Previous 347,252 0.37%
Holding current value
$130 Million
Previous $120 Million 20.74%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$268.26 - $339.48 $345,518 - $437,250
1,288 Added 0.37%
348,540 $95.2 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $7.59 Million - $8.78 Million
24,958 Added 7.74%
347,252 $120 Million
Q4 2023

Feb 08, 2024

SELL
$269.37 - $365.04 $383,313 - $519,451
-1,423 Reduced 0.44%
322,294 $104 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $113 Million - $137 Million
323,717 New
323,717 $116 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $9.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.